| Annual Financials | 2025 | TTM |
Revenue  | 98 | 0 |
| Expenses | 76 | 0 |
| EBITDA | 21 | 0 |
| Operating Profit % | 22 % | 0 % |
| Depreciation | 2 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 19 | 0 |
| Tax | 5 | 0 |
| Net Profit | 15 | 0 |
| EPS in ₹ | 9.11 | 0.00 |
Monolithisch
Monolithisch
464.75
-15.25
(-3.18%)
Market Cap
1,010.20 Cr
EPS
9.11
PE Ratio
69.68
Dividend Yield
0.00 %
Industry
-52 Week High
498.95
52 Week Low
219.45
PB Ratio
8.62
Debt to Equity
0.21
Sector
-
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Monolithisch India Ltd aims to capture 25-30% of the premixed ramming mass market within the next couple of years, up from its current 8-9% market share. Managing Director Harsh Tekriwal expects the market to grow from 2 lakh tonnes monthly to 4-5 lakh tonnes monthly over the next 2-3 years. The company is expanding capacity to 5.74 lakh tonnes per annum within one year, having recently commissioned the first phase at its Purulia plant, bringing installed capacity to 206,000 TPA. Revenue increased from Rs 68 crore in 2023-24 to Rs 97 crore in 2024-25. The company went public in June and raised Rs 82.02 crore through its IPO for machinery upgrades, a greenfield project, and working capital. Premixed ramming mass is used for lining induction furnaces in the secondary steel sector, which Tekriwal describes as booming due to economic advantages and improving product quality.
Monolithisch India announced the opening of Capex-I at its Purulia plant on October 2, 2025. The expansion will increase the plant's capacity to 206,000 tonnes per annum (TPA) to address growing demand for ramming mass products.
Mukul Agrawal's recent investment Monolithisch India has delivered nearly 200% returns in 44 days since its listing on June 19. The stock debuted on NSE's SME platform following its June IPO and ranks as the second-best performer in Agrawal's portfolio. Two other June quarter additions, Yatharth Hospital and Tatva Chintan Pharma Chem, have gained 67% and 53% respectively. Agrawal holds stakes of 2.3% in Monolithisch, 1.1% in Yatharth, and 1.3% in Tatva Chintan. His portfolio consists of 64 stocks with a net worth exceeding Rs 7,506 crore, growing over 10% since June. Five other June picks have returned between 8% and 16%. During the quarter, Agrawal increased his stake in Prakash Industries to 1.7% and reduced holdings in five stocks while potentially exiting two others. Of his 64 holdings, 18 have delivered negative returns of up to 30%.
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-58.83 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2025 |
| Total Assets | 56 |
| Fixed Assets | 12 |
| Current Assets | 40 |
| Capital Work in Progress | 0 |
| Investments | 0 |
| Other Assets | 44 |
| Total Liabilities | 56 |
| Current Liabilities | 21 |
| Non Current Liabilities | 0 |
| Total Equity | 35 |
| Reserve & Surplus | 19 |
| Share Capital | 16 |
Cash Flow
| Cash Flow | 2025 |
| Net Cash Flow | 0 |
| Investing Activities | -11 |
| Operating Activities | 4 |
| Financing Activities | 7 |
Share Holding
| % Holding | Dec 2024 | Feb 2025 | Jun 2025 |
| Promoter | 100.00 % | 100.00 % | 73.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 13.57 % |
| Others | 0.00 % | 0.00 % | 12.81 % |
| No of Share Holders | 7 | 7 | 7 |
Technical Indicators
RSI(14)
Neutral 55.51
ATR(14)
Volatile 18.82
STOCH(9,6)
Neutral 73.84
STOCH RSI(14)
Neutral 27.37
MACD(12,26)
Bearish -2.33
ADX(14)
Weak Trend 22.87
UO(9)
Bearish 55.38
ROC(12)
Downtrend And Accelerating -2.37
WillR(14)
Neutral -52.36
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
